$MGNX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in MACROGENICS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in MACROGENICS INC. Get notifications about new insider transactions in MACROGENICS INC for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 20 2016 | MGNX | MACROGENICS INC | STUMP DAVID C | Director | Option Exercise | A | 21.06 | 8,500 | 179,010 | 8,500 | |
May 20 2016 | MGNX | MACROGENICS INC | Fust Matthew K | Director | Option Exercise | A | 21.06 | 8,500 | 179,010 | 8,500 | |
May 20 2016 | MGNX | MACROGENICS INC | Costa Paulo F | Director | Option Exercise | A | 21.06 | 5,674 | 119,494 | 5,674 | |
May 20 2016 | MGNX | MACROGENICS INC | Costa Paulo F | Director | Option Exercise | A | 21.06 | 8,500 | 179,010 | 8,500 | |
May 17 2016 | MGNX | MACROGENICS INC | Koenig Scott | President and CEO | Option Exercise | M | 0.94 | 26,631 | 25,033 | 79,897 | |
May 17 2016 | MGNX | MACROGENICS INC | Koenig Scott | President and CEO | Option Exercise | M | 0.94 | 7,988 | 7,509 | 0 | |
May 17 2016 | MGNX | MACROGENICS INC | Koenig Scott | President and CEO | Buy | M | 0.94 | 34,619 | 32,542 | 167,782 | 133.2 K to 167.8 K (+26.00 %) |
May 13 2016 | MGNX | MACROGENICS INC | Koenig Scott | President and CEO | Option Exercise | M | 0.94 | 79,898 | 75,104 | 79,898 | |
May 13 2016 | MGNX | MACROGENICS INC | Koenig Scott | President and CEO | Buy | M | 0.94 | 79,898 | 75,104 | 133,163 | 53.3 K to 133.2 K (+150.00 %) |
Apr 29 2016 | MGNX | MACROGENICS INC | SARAN ATUL | SVP & General Couns ... | Payment of Exercise | F | 20.84 | 1,730 | 36,053 | 18,980 | 20.7 K to 19 K (-8.35 %) |
Mar 04 2016 | MGNX | MACROGENICS INC | Costa Paulo F | Director | Buy | P | 17.20 | 10,000 | 172,000 | 59,435 | 49.4 K to 59.4 K (+20.23 %) |
Feb 29 2016 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP, Clinical Dev ... | Grant | A | 0.00 | 30,000 | 0 | 30,000 | 0 to 30 K |
Feb 10 2016 | MGNX | MACROGENICS INC | Risser Eric Blasius | SVP, Business Devel ... | Option Exercise | M | 0.94 | 2,500 | 2,350 | 3,836 | |
Feb 10 2016 | MGNX | MACROGENICS INC | Risser Eric Blasius | SVP, Business Devel ... | Buy | M | 0.94 | 2,500 | 2,350 | 4,000 | 1.5 K to 4 K (+166.67 %) |
Feb 02 2016 | MGNX | MACROGENICS INC | Karrels James | SVP, CFO and Secret ... | Option Exercise | D | 0.94 | 10,000 | 9,400 | 19,516 | |
Feb 02 2016 | MGNX | MACROGENICS INC | Karrels James | SVP, CFO and Secret ... | Buy | M | 0.94 | 10,000 | 9,400 | 100,331 | 90.3 K to 100.3 K (+11.07 %) |
Jan 11 2016 | MGNX | MACROGENICS INC | Stein Kathryn E | SVP, Product Dev. & ... | Option Exercise | M | 0.71 | 19,060 | 13,533 | 0 | |
Jan 11 2016 | MGNX | MACROGENICS INC | Stein Kathryn E | SVP, Product Dev. & ... | Option Exercise | M | 0.94 | 13,316 | 12,517 | 0 | |
Jan 11 2016 | MGNX | MACROGENICS INC | Stein Kathryn E | SVP, Product Dev. & ... | Option Exercise | M | 0.94 | 4,421 | 4,156 | 0 | |
Jan 11 2016 | MGNX | MACROGENICS INC | Stein Kathryn E | SVP, Product Dev. & ... | Option Exercise | M | 0.94 | 8,895 | 8,361 | 0 | |
Jan 11 2016 | MGNX | MACROGENICS INC | Stein Kathryn E | SVP, Product Dev. & ... | Option Exercise | M | 0.94 | 6,658 | 6,259 | 0 | |
Jan 11 2016 | MGNX | MACROGENICS INC | Stein Kathryn E | SVP, Product Dev. & ... | Buy | M | 0.71 | 19,060 | 13,533 | 95,555 | 76.5 K to 95.6 K (+24.92 %) |
Jan 11 2016 | MGNX | MACROGENICS INC | Stein Kathryn E | SVP, Product Dev. & ... | Buy | M | 0.94 | 13,316 | 12,517 | 79,495 | 66.2 K to 79.5 K (+20.12 %) |
Jan 11 2016 | MGNX | MACROGENICS INC | Stein Kathryn E | SVP, Product Dev. & ... | Buy | M | 0.94 | 4,421 | 4,156 | 63,179 | 58.8 K to 63.2 K (+7.52 %) |
Jan 11 2016 | MGNX | MACROGENICS INC | Stein Kathryn E | SVP, Product Dev. & ... | Buy | M | 0.94 | 8,895 | 8,361 | 58,758 | 49.9 K to 58.8 K (+17.84 %) |
Jan 11 2016 | MGNX | MACROGENICS INC | Stein Kathryn E | SVP, Product Dev. & ... | Buy | M | 0.94 | 6,658 | 6,259 | 49,863 | 43.2 K to 49.9 K (+15.41 %) |
Jan 11 2016 | MGNX | MACROGENICS INC | Bonvini Ezio | Senior VP, Research | Option Exercise | M | 0.94 | 8,895 | 8,361 | 0 | |
Jan 11 2016 | MGNX | MACROGENICS INC | Bonvini Ezio | Senior VP, Research | Option Exercise | M | 0.94 | 4,421 | 4,156 | 0 | |
Jan 11 2016 | MGNX | MACROGENICS INC | Bonvini Ezio | Senior VP, Research | Buy | M | 0.94 | 8,895 | 8,361 | 83,633 | 74.7 K to 83.6 K (+11.90 %) |
Jan 11 2016 | MGNX | MACROGENICS INC | Bonvini Ezio | Senior VP, Research | Buy | M | 0.94 | 4,421 | 4,156 | 74,738 | 70.3 K to 74.7 K (+6.29 %) |
Jan 06 2016 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP, Clinical | Option Exercise | M | 4.70 | 10,000 | 47,000 | 60,254 | |
Jan 06 2016 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP, Clinical | Sell | S | 29.64 | 10,000 | 296,400 | 0 | 10 K to 0 (-100.00 %) |
Jan 06 2016 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP, Clinical | Buy | M | 4.70 | 10,000 | 47,000 | 10,000 | 0 to 10 K |
Dec 23 2015 | MGNX | MACROGENICS INC | Risser Eric Blasius | SVP, Business Devel ... | Option Exercise | M | 0.94 | 1,500 | 1,410 | 14,336 | |
Dec 23 2015 | MGNX | MACROGENICS INC | Risser Eric Blasius | SVP, Business Devel ... | Buy | M | 0.94 | 1,500 | 1,410 | 1,500 | 0 to 1.5 K |
Dec 22 2015 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP, Clinical | Option Exercise | A | 31.43 | 55,000 | 1,728,650 | 55,000 | |
Dec 22 2015 | MGNX | MACROGENICS INC | SARAN ATUL | Sr. VP and General ... | Option Exercise | A | 31.43 | 45,000 | 1,414,350 | 45,000 | |
Dec 22 2015 | MGNX | MACROGENICS INC | Risser Eric Blasius | SVP, Business Devel ... | Option Exercise | A | 31.43 | 45,000 | 1,414,350 | 45,000 | |
Dec 22 2015 | MGNX | MACROGENICS INC | Koenig Scott | President and CEO | Option Exercise | A | 31.43 | 150,000 | 4,714,500 | 150,000 | |
Dec 22 2015 | MGNX | MACROGENICS INC | Karrels James | SVP, CFO and Secret ... | Option Exercise | A | 31.43 | 45,000 | 1,414,350 | 45,000 | |
Dec 22 2015 | MGNX | MACROGENICS INC | Cilinski Lynn | VP, Controller and ... | Option Exercise | A | 31.43 | 22,000 | 691,460 | 22,000 | |
Dec 22 2015 | MGNX | MACROGENICS INC | Bonvini Ezio | Senior VP, Research | Option Exercise | A | 31.43 | 55,000 | 1,728,650 | 55,000 | |
Nov 24 2015 | MGNX | MACROGENICS INC | Cilinski Lynn | VP, Controller and ... | Option Exercise | M | 0.94 | 3,815 | 3,586 | 9,501 | |
Nov 24 2015 | MGNX | MACROGENICS INC | Cilinski Lynn | VP, Controller and ... | Option Exercise | M | 0.94 | 1,185 | 1,114 | 0 | |
Nov 24 2015 | MGNX | MACROGENICS INC | Cilinski Lynn | VP, Controller and ... | Sell | S | 35.00 | 1,921 | 67,235 | 1,923 | 3.8 K to 1.9 K (-49.97 %) |
Nov 24 2015 | MGNX | MACROGENICS INC | Cilinski Lynn | VP, Controller and ... | Sell | S | 35.00 | 3,815 | 133,525 | 3,844 | 7.7 K to 3.8 K (-49.81 %) |
Nov 24 2015 | MGNX | MACROGENICS INC | Cilinski Lynn | VP, Controller and ... | Buy | M | 0.94 | 3,815 | 3,586 | 7,659 | 3.8 K to 7.7 K (+99.25 %) |
Nov 24 2015 | MGNX | MACROGENICS INC | Cilinski Lynn | VP, Controller and ... | Sell | S | 35.00 | 1,185 | 41,475 | 3,844 | 5 K to 3.8 K (-23.56 %) |
Nov 24 2015 | MGNX | MACROGENICS INC | Cilinski Lynn | VP, Controller and ... | Buy | M | 0.94 | 1,185 | 1,114 | 5,029 | 3.8 K to 5 K (+30.83 %) |
Nov 17 2015 | MGNX | MACROGENICS INC | Bonvini Ezio | Senior VP, Research | Sell | S | 31.44 | 3,117 | 97,998 | 70,317 | 73.4 K to 70.3 K (-4.24 %) |
Oct 19 2015 | MGNX | MACROGENICS INC | Bonvini Ezio | Senior VP, Research | Sell | S | 25.21 | 6,233 | 157,134 | 73,434 | 79.7 K to 73.4 K (-7.82 %) |
Oct 15 2015 | MGNX | MACROGENICS INC | Bonvini Ezio | Senior VP, Research | Option Exercise | M | 0.71 | 14,521 | 10,310 | 0 | |
Oct 15 2015 | MGNX | MACROGENICS INC | Bonvini Ezio | Senior VP, Research | Sell | M | 25.53 | 14,521 | 370,721 | 79,667 | 94.2 K to 79.7 K (-15.42 %) |
Oct 15 2015 | MGNX | MACROGENICS INC | Bonvini Ezio | Senior VP, Research | Buy | M | 0.71 | 14,521 | 10,310 | 94,188 | 79.7 K to 94.2 K (+18.23 %) |
Oct 09 2015 | MGNX | MACROGENICS INC | Karrels James | SVP, CFO and Secret ... | Option Exercise | M | 0.94 | 6,000 | 5,640 | 16,533 | |
Oct 09 2015 | MGNX | MACROGENICS INC | Karrels James | SVP, CFO and Secret ... | Buy | M | 0.94 | 6,000 | 5,640 | 10,100 | 4.1 K to 10.1 K (+146.34 %) |
Oct 06 2015 | MGNX | MACROGENICS INC | Bonvini Ezio | Senior VP, Research | Option Exercise | M | 0.94 | 11,984 | 11,265 | 0 | |
Oct 06 2015 | MGNX | MACROGENICS INC | Bonvini Ezio | Senior VP, Research | Option Exercise | M | 0.94 | 5,893 | 5,539 | 0 | |
Oct 06 2015 | MGNX | MACROGENICS INC | Bonvini Ezio | Senior VP, Research | Buy | M | 0.94 | 5,893 | 5,539 | 79,667 | 73.8 K to 79.7 K (+7.99 %) |
Oct 06 2015 | MGNX | MACROGENICS INC | Bonvini Ezio | Senior VP, Research | Buy | M | 0.94 | 11,984 | 11,265 | 73,774 | 61.8 K to 73.8 K (+19.39 %) |
Oct 02 2015 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP, Clinical | Option Exercise | M | 4.70 | 5,000 | 23,500 | 45,194 | |
Oct 02 2015 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP, Clinical | Sell | S | 21.11 | 5,000 | 105,550 | 0 | 5 K to 0 (-100.00 %) |
Oct 02 2015 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP, Clinical | Buy | M | 4.70 | 5,000 | 23,500 | 5,000 | 0 to 5 K |
Sep 22 2015 | MGNX | MACROGENICS INC | Bonvini Ezio | Senior VP, Research | Option Exercise | M | 0.94 | 7,000 | 6,580 | 5,893 | |
Sep 22 2015 | MGNX | MACROGENICS INC | Bonvini Ezio | Senior VP, Research | Buy | M | 0.94 | 7,000 | 6,580 | 61,790 | 54.8 K to 61.8 K (+12.78 %) |
Sep 18 2015 | MGNX | MACROGENICS INC | Bonvini Ezio | Senior VP, Research | Option Exercise | M | 0.94 | 4,000 | 3,760 | 12,893 | |
Sep 18 2015 | MGNX | MACROGENICS INC | Bonvini Ezio | Senior VP, Research | Buy | M | 0.94 | 4,000 | 3,760 | 54,790 | 50.8 K to 54.8 K (+7.88 %) |
Aug 28 2015 | MGNX | MACROGENICS INC | Bonvini Ezio | Senior VP, Research | Option Exercise | M | 0.94 | 5,000 | 4,700 | 16,893 | |
Aug 28 2015 | MGNX | MACROGENICS INC | Bonvini Ezio | Senior VP, Research | Option Exercise | M | 0.94 | 5,000 | 4,700 | 21,893 | |
Aug 28 2015 | MGNX | MACROGENICS INC | Bonvini Ezio | Senior VP, Research | Buy | M | 0.94 | 5,000 | 4,700 | 50,790 | 45.8 K to 50.8 K (+10.92 %) |
Aug 28 2015 | MGNX | MACROGENICS INC | Bonvini Ezio | Senior VP, Research | Buy | M | 0.94 | 5,000 | 4,700 | 45,790 | 40.8 K to 45.8 K (+12.26 %) |
Aug 11 2015 | MGNX | MACROGENICS INC | Bonvini Ezio | Senior VP, Research | Option Exercise | M | 0.95 | 4,000 | 3,800 | 26,893 | |
Aug 11 2015 | MGNX | MACROGENICS INC | Bonvini Ezio | Senior VP, Research | Buy | M | 0.94 | 4,000 | 3,760 | 40,790 | 36.8 K to 40.8 K (+10.87 %) |
Aug 03 2015 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP, Clinical | Option Exercise | M | 4.70 | 10,000 | 47,000 | 50,194 | |
Aug 03 2015 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP, Clinical | Sell | S | 37.15 | 10,000 | 371,500 | 0 | 10 K to 0 (-100.00 %) |
Aug 03 2015 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP, Clinical | Buy | M | 4.70 | 10,000 | 47,000 | 10,000 | 0 to 10 K |
Jul 13 2015 | MGNX | MACROGENICS INC | Bonvini Ezio | Senior VP, Research | Option Exercise | M | 0.71 | 2,400 | 1,704 | 14,521 | |
Jul 13 2015 | MGNX | MACROGENICS INC | Bonvini Ezio | Senior VP, Research | Sell | S | 38.09 | 2,400 | 91,416 | 36,790 | 39.2 K to 36.8 K (-6.12 %) |
Jul 13 2015 | MGNX | MACROGENICS INC | Bonvini Ezio | Senior VP, Research | Buy | M | 0.71 | 2,400 | 1,704 | 39,190 | 36.8 K to 39.2 K (+6.52 %) |
Jul 01 2015 | MGNX | MACROGENICS INC | Cilinski Lynn | VP, Controller and ... | Option Exercise | M | 0.94 | 5,000 | 4,700 | 1,185 | |
Jul 01 2015 | MGNX | MACROGENICS INC | Cilinski Lynn | VP, Controller and ... | Sell | S | 37.15 | 1,921 | 71,365 | 3,844 | 5.8 K to 3.8 K (-33.32 %) |
Jul 01 2015 | MGNX | MACROGENICS INC | Cilinski Lynn | VP, Controller and ... | Sell | S | 37.15 | 5,000 | 185,750 | 5,765 | 10.8 K to 5.8 K (-46.45 %) |
Jul 01 2015 | MGNX | MACROGENICS INC | Cilinski Lynn | VP, Controller and ... | Buy | M | 0.94 | 5,000 | 4,700 | 10,765 | 5.8 K to 10.8 K (+86.73 %) |
Jul 01 2015 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP, Clinical | Option Exercise | M | 4.70 | 5,000 | 23,500 | 60,194 | |
Jul 01 2015 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP, Clinical | Sell | S | 37.15 | 5,000 | 185,750 | 0 | 5 K to 0 (-100.00 %) |
Jul 01 2015 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP, Clinical | Buy | M | 4.70 | 5,000 | 23,500 | 5,000 | 0 to 5 K |
Jul 01 2015 | MGNX | MACROGENICS INC | Bonvini Ezio | Senior VP, Research | Option Exercise | M | 0.71 | 6,497 | 4,613 | 16,921 | |
Jul 01 2015 | MGNX | MACROGENICS INC | Bonvini Ezio | Senior VP, Research | Sell | S | 38.07 | 6,497 | 247,341 | 36,790 | 43.3 K to 36.8 K (-15.01 %) |
Jul 01 2015 | MGNX | MACROGENICS INC | Bonvini Ezio | Senior VP, Research | Buy | M | 0.71 | 6,497 | 4,613 | 43,287 | 36.8 K to 43.3 K (+17.66 %) |
Jun 25 2015 | MGNX | MACROGENICS INC | Bonvini Ezio | Senior VP, Research | Sell | S | 38.08 | 6,097 | 232,174 | 17,639 | 23.7 K to 17.6 K (-25.69 %) |
Jun 24 2015 | MGNX | MACROGENICS INC | Bonvini Ezio | Senior VP, Research | Sell | S | 38.14 | 13,054 | 497,880 | 23,736 | 36.8 K to 23.7 K (-35.48 %) |
Jun 16 2015 | MGNX | MACROGENICS INC | Cilinski Lynn | VP, Controller and ... | Option Exercise | M | 0.94 | 5,000 | 4,700 | 6,185 | |
Jun 16 2015 | MGNX | MACROGENICS INC | Cilinski Lynn | VP, Controller and ... | Sell | S | 35.00 | 5,700 | 199,500 | 5,765 | 11.5 K to 5.8 K (-49.72 %) |
Jun 16 2015 | MGNX | MACROGENICS INC | Cilinski Lynn | VP, Controller and ... | Sell | S | 35.00 | 5,000 | 175,000 | 11,465 | 16.5 K to 11.5 K (-30.37 %) |
Jun 16 2015 | MGNX | MACROGENICS INC | Cilinski Lynn | VP, Controller and ... | Buy | M | 0.94 | 5,000 | 4,700 | 16,465 | 11.5 K to 16.5 K (+43.61 %) |
Jun 16 2015 | MGNX | MACROGENICS INC | Bonvini Ezio | Senior VP, Research | Option Exercise | M | 0.71 | 6,233 | 4,425 | 42,569 | |
Jun 16 2015 | MGNX | MACROGENICS INC | Bonvini Ezio | Senior VP, Research | Sell | S | 34.01 | 6,233 | 211,984 | 36,790 | 43 K to 36.8 K (-14.49 %) |
Jun 16 2015 | MGNX | MACROGENICS INC | Bonvini Ezio | Senior VP, Research | Buy | M | 0.71 | 6,233 | 4,425 | 43,023 | 36.8 K to 43 K (+16.94 %) |
May 21 2015 | MGNX | MACROGENICS INC | STUMP DAVID C | Director | Option Exercise | A | 32.34 | 8,500 | 274,890 | 8,500 | |
May 21 2015 | MGNX | MACROGENICS INC | HURWITZ EDWARD | Director | Option Exercise | A | 32.34 | 8,500 | 274,890 | 8,500 | |
May 21 2015 | MGNX | MACROGENICS INC | Galbraith Kenneth | Director | Option Exercise | A | 32.34 | 8,500 | 274,890 | 8,500 | |
May 21 2015 | MGNX | MACROGENICS INC | Fust Matthew K | Director | Option Exercise | A | 32.34 | 8,500 | 274,890 | 8,500 | |
May 21 2015 | MGNX | MACROGENICS INC | Costa Paulo F | Director | Option Exercise | A | 32.34 | 3,313 | 107,142 | 3,313 | |
May 21 2015 | MGNX | MACROGENICS INC | Costa Paulo F | Director | Option Exercise | A | 32.34 | 8,500 | 274,890 | 8,500 | |
May 18 2015 | MGNX | MACROGENICS INC | Bonvini Ezio | Senior VP, Research | Option Exercise | M | 0.71 | 6,233 | 4,425 | 48,802 | |
May 18 2015 | MGNX | MACROGENICS INC | Bonvini Ezio | Senior VP, Research | Sell | S | 30.24 | 6,233 | 188,486 | 36,790 | 43 K to 36.8 K (-14.49 %) |
May 18 2015 | MGNX | MACROGENICS INC | Bonvini Ezio | Senior VP, Research | Buy | M | 0.71 | 6,233 | 4,425 | 43,023 | 36.8 K to 43 K (+16.94 %) |
May 13 2015 | MGNX | MACROGENICS INC | HURWITZ EDWARD | Director | Buy | J | 0.00 | 18,074 | 0 | 18,074 | 0 to 18.1 K |
Apr 29 2015 | MGNX | MACROGENICS INC | SARAN ATUL | General Counsel | Payment of Exercise | F | 32.02 | 925 | 29,619 | 20,710 | 21.6 K to 20.7 K (-4.28 %) |
Apr 16 2015 | MGNX | MACROGENICS INC | Bonvini Ezio | Senior VP, Research | Option Exercise | M | 0.71 | 6,233 | 4,425 | 55,035 | |
Apr 16 2015 | MGNX | MACROGENICS INC | Bonvini Ezio | Senior VP, Research | Sell | S | 33.98 | 6,233 | 211,797 | 36,790 | 43 K to 36.8 K (-14.49 %) |
Apr 16 2015 | MGNX | MACROGENICS INC | Bonvini Ezio | Senior VP, Research | Buy | M | 0.71 | 6,233 | 4,425 | 43,023 | 36.8 K to 43 K (+16.94 %) |
Apr 03 2015 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP, Clinical | Option Exercise | M | 4.70 | 5,000 | 23,500 | 65,194 | |
Apr 03 2015 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP, Clinical | Sell | S | 30.86 | 5,000 | 154,300 | 0 | 5 K to 0 (-100.00 %) |
Apr 03 2015 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP, Clinical | Buy | M | 4.70 | 5,000 | 23,500 | 5,000 | 0 to 5 K |
Feb 03 2015 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP, Clinical | Option Exercise | M | 4.70 | 5,000 | 23,500 | 70,194 | |
Feb 03 2015 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP, Clinical | Sell | S | 31.04 | 5,000 | 155,200 | 0 | 5 K to 0 (-100.00 %) |
Feb 03 2015 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP, Clinical | Buy | M | 4.70 | 5,000 | 23,500 | 5,000 | 0 to 5 K |
Dec 29 2014 | MGNX | MACROGENICS INC | Karrels James | VP, CFO and Secreta ... | Option Exercise | M | 0.94 | 4,100 | 3,854 | 22,533 | |
Dec 29 2014 | MGNX | MACROGENICS INC | Karrels James | VP, CFO and Secreta ... | Buy | M | 0.94 | 4,100 | 3,854 | 4,100 | 0 to 4.1 K |
Dec 23 2014 | MGNX | MACROGENICS INC | Stein Kathryn E | SVP, Product Dev. & ... | Option Exercise | M | 0.71 | 10,946 | 7,772 | 19,060 | |
Dec 23 2014 | MGNX | MACROGENICS INC | Stein Kathryn E | SVP, Product Dev. & ... | Sell | S | 37.00 | 10,946 | 405,002 | 43,205 | 54.2 K to 43.2 K (-20.21 %) |
Dec 23 2014 | MGNX | MACROGENICS INC | Stein Kathryn E | SVP, Product Dev. & ... | Buy | M | 0.07 | 10,946 | 777 | 54,151 | 43.2 K to 54.2 K (+25.34 %) |
Dec 23 2014 | MGNX | MACROGENICS INC | Risser Eric Blasius | VP, Business Develo ... | Option Exercise | M | 0.94 | 5,000 | 4,700 | 15,836 | |
Dec 23 2014 | MGNX | MACROGENICS INC | Risser Eric Blasius | VP, Business Develo ... | Sell | M | 38.25 | 5,000 | 191,250 | 0 | 5 K to 0 (-100.00 %) |
Dec 23 2014 | MGNX | MACROGENICS INC | Risser Eric Blasius | VP, Business Develo ... | Buy | M | 0.94 | 5,000 | 4,700 | 5,000 | 0 to 5 K |
Dec 22 2014 | MGNX | MACROGENICS INC | Risser Eric Blasius | VP, Business Develo ... | Option Exercise | M | 0.09 | 10,000 | 940 | 20,836 | |
Dec 22 2014 | MGNX | MACROGENICS INC | Risser Eric Blasius | VP, Business Develo ... | Sell | S | 33.50 | 10,000 | 335,000 | 0 | 10 K to 0 (-100.00 %) |
Dec 22 2014 | MGNX | MACROGENICS INC | Risser Eric Blasius | VP, Business Develo ... | Buy | M | 0.94 | 10,000 | 9,400 | 10,000 | 0 to 10 K |
Dec 22 2014 | MGNX | MACROGENICS INC | Stein Kathryn E | SVP, Product Dev. & ... | Option Exercise | M | 0.71 | 10,946 | 7,772 | 30,006 | |
Dec 22 2014 | MGNX | MACROGENICS INC | Stein Kathryn E | SVP, Product Dev. & ... | Sell | S | 33.00 | 10,946 | 361,218 | 43,205 | 54.2 K to 43.2 K (-20.21 %) |
Dec 22 2014 | MGNX | MACROGENICS INC | Stein Kathryn E | SVP, Product Dev. & ... | Buy | M | 0.71 | 10,946 | 7,772 | 54,151 | 43.2 K to 54.2 K (+25.34 %) |
Dec 22 2014 | MGNX | MACROGENICS INC | Koenig Scott | President and CEO | Option Exercise | M | 0.94 | 62,205 | 58,473 | 0 | |
Dec 22 2014 | MGNX | MACROGENICS INC | Koenig Scott | President and CEO | Buy | M | 0.94 | 62,205 | 58,473 | 703,414 | 641.2 K to 703.4 K (+9.70 %) |
Dec 16 2014 | MGNX | MACROGENICS INC | Wigginton Jon Marc | Sr VP, Clinical | Option Exercise | A | 29.68 | 40,000 | 1,187,200 | 40,000 | |
Dec 16 2014 | MGNX | MACROGENICS INC | Stein Kathryn E | Senior VP, Prd Dev ... | Option Exercise | A | 29.68 | 10,000 | 296,800 | 10,000 | |
Dec 16 2014 | MGNX | MACROGENICS INC | SARAN ATUL | Sr. VP and General ... | Option Exercise | A | 29.68 | 30,000 | 890,400 | 30,000 | |
Dec 16 2014 | MGNX | MACROGENICS INC | Risser Eric Blasius | VP, Business Develo ... | Option Exercise | A | 29.68 | 50,000 | 1,484,000 | 50,000 | |
Dec 16 2014 | MGNX | MACROGENICS INC | Koenig Scott | President and CEO | Option Exercise | A | 29.68 | 140,000 | 4,155,200 | 140,000 | |
Dec 16 2014 | MGNX | MACROGENICS INC | Karrels James | VP, CFO and Secreta ... | Option Exercise | A | 29.68 | 40,000 | 1,187,200 | 40,000 | |
Dec 16 2014 | MGNX | MACROGENICS INC | Cilinski Lynn | VP, Controller and ... | Option Exercise | A | 29.68 | 30,000 | 890,400 | 30,000 | |
Dec 16 2014 | MGNX | MACROGENICS INC | Bonvini Ezio | Senior VP, Research | Option Exercise | A | 29.68 | 50,000 | 1,484,000 | 50,000 | |
Nov 25 2014 | MGNX | MACROGENICS INC | Risser Eric Blasius | VP, Business Develo ... | Option Exercise | M | 0.94 | 10,000 | 9,400 | 30,836 | |
Nov 25 2014 | MGNX | MACROGENICS INC | Risser Eric Blasius | VP, Business Develo ... | Sell | S | 27.75 | 10,000 | 277,500 | 0 | 10 K to 0 (-100.00 %) |
Nov 25 2014 | MGNX | MACROGENICS INC | Risser Eric Blasius | VP, Business Develo ... | Buy | M | 0.94 | 10,000 | 9,400 | 10,000 | 0 to 10 K |
Nov 24 2014 | MGNX | MACROGENICS INC | Stein Kathryn E | Senior VP, Prd Dev ... | Option Exercise | M | 0.71 | 10,946 | 7,772 | 41,245 | |
Nov 24 2014 | MGNX | MACROGENICS INC | Stein Kathryn E | Senior VP, Prd Dev ... | Sell | S | 27.00 | 10,946 | 295,542 | 43,205 | 54.2 K to 43.2 K (-20.21 %) |
Nov 24 2014 | MGNX | MACROGENICS INC | Stein Kathryn E | Senior VP, Prd Dev ... | Buy | M | 0.71 | 10,946 | 7,772 | 54,151 | 43.2 K to 54.2 K (+25.34 %) |
Nov 17 2014 | MGNX | MACROGENICS INC | Stein Kathryn E | Senior VP, Prd Dev ... | Option Exercise | M | 0.94 | 2,090 | 1,965 | 0 | |
Nov 17 2014 | MGNX | MACROGENICS INC | Stein Kathryn E | Senior VP, Prd Dev ... | Option Exercise | M | 0.94 | 23,211 | 21,818 | 2,090 |